ERYILMAZ, M. K. Et Al. 2016. Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.3 , 533-536.

ERYILMAZ, M. K., Mutlu, H., SALIM, D. K., MUSRI, F. Y., Tural, D., Bassorgun, I., ... COŞKUN, H. Ş.(2016). Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.3, 533-536.

ERYILMAZ, Melek Et Al. "Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.3, 533-536, 2016

ERYILMAZ, Melek K. Et Al. "Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.3, pp.533-536, 2016

ERYILMAZ, M. K. Et Al. (2016) . "Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.3, pp.533-536.

@article{article, author={Melek Karakurt ERYILMAZ Et Al. }, title={Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2016, pages={533-536} }